VolitionRx Limited (VNRX) is a publicly traded Healthcare sector company. As of May 21, 2026, VNRX trades at $2.45 with a market cap of $18.44M and a P/E ratio of 0.00. VNRX moved +5.53% today. Year to date, VNRX is -55.55%; over the trailing twelve months it is -74.64%. Its 52-week range spans $1.91 to $18.80. Analyst consensus is buy with an average price target of $40.00. Rallies surfaces VNRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading VNRX stock inside the company?
Recent VNRX insider activity includes Reynolds Cameron John bought 20.00K, Reynolds Cameron John bought 110.00K, Innes Guy Archibald bought 96.15K, and STILL TIMOTHY I bought 48.08K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
VNRX Key Metrics
Key financial metrics for VNRX
Metric
Value
Price
$2.45
Market Cap
$18.44M
P/E Ratio
0.00
EPS
$0.00
Dividend Yield
0.00%
52-Week High
$18.80
52-Week Low
$1.91
Volume
2.85K
Avg Volume
0
Revenue (TTM)
$2.47M
Net Income
$-24.73M
Gross Margin
0.00%
Recent VNRX Insider Trades
Reynolds Cameron John bought 20.00K (~$7.00K) on Nov 17, 2025.
Reynolds Cameron John bought 110.00K (~$56.10K) on Oct 14, 2025.
Innes Guy Archibald bought 96.15K (~$49.04K) on Oct 14, 2025.
STILL TIMOTHY I bought 48.08K (~$24.52K) on Oct 14, 2025.
Recent VNRX insider activity includes Reynolds Cameron John bought 20.00K, Reynolds Cameron John bought 110.00K, Innes Guy Archibald bought 96.15K, and STILL TIMOTHY I bought 48.08K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for VNRX?
Yes. Rallies tracks VNRX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is VNRX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for VNRX. It does not provide personalized investment advice.
